Ligand Pharmaceuticals Incorporated (LGND)
Debt-to-assets ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total assets | US$ in thousands | 941,774 | 787,216 | 762,668 | 1,301,380 | 1,362,280 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $941,774K
= 0.00
The debt-to-assets ratio for Ligand Pharmaceuticals Incorporated has remained consistently at 0.00 from December 31, 2020, to December 31, 2024. This indicates that the company has no debt in relation to its total assets throughout the period. A low or zero debt-to-assets ratio can suggest a strong financial position, as it signifies that the company is not relying heavily on debt to finance its operations or investments. Ligand Pharmaceuticals' consistent zero debt-to-assets ratio reflects a conservative financial strategy with little financial leverage and potentially lower financial risk.
Peer comparison
Dec 31, 2024